Maybank Kim Eng Research

Analysts are maintaining a cautious stance on Raffles Medical Group following the announcement of its 1H2020 results on July 27.

Frasers Centrepoint Trust (FCT)’s operational update on July 20 reported a dip in 1.5 percentage points q-o-q to 94.6% for 3Q20, led by Bedok Point (at -3.7 percentage points q-o-q), and YewTee Point (-2.6 percentage points q-o-q).

Maybank’s Kim Eng Research has kept its “buy” call for Mapletree Commercial Trust (MCT) with an unchanged target price of $2.15.

Following the release of advance gross domestic product (GDP) estimates by the Ministry of Trade and Industry on Tuesday morning, economists are buoyant on Singapore’s economic outlook, despite the dismal numbers reported in 2Q20.

Strong growth prospects and relative resilience against Covid-19 makes Francken a hidden gem.

Following the People’s Action Party’s (PAP) victory in the general election last Friday, brokers have expected policy continuity in the country as Singapore continues to battle the COVID-19 pandemic.

Analysts may be mixed on the REIT, but they have all cut their DPU estimates for FY20.

Notably, utilisation levels, especially in the services and construction sectors, are expected to remain low, says Maybank Kim Eng analyst Thilan Wickramasinghe.

CGS-CIMB Research has downgraded the stock to "hold" while Maybank has maintained its "buy" call.

Wickramasinghe says that although Singapore may likely witness one of its strongest contractions in the region, this may not translate directly to its banking system.